Miscoding properties of 1,N6-ethanoadenine, a DNA adduct derived from reaction with the antitumor agent 1,3-bis(2-chloroethyl)-1- nitrosourea

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 531, Issue 1-2, 2003, Pages 191-203

  Hang, Bo ^a   Chenna, Ahmed ^a,b   Guliaev, Anton B ^a   Singer, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ACLARA BioSciences Inc   (United States)

Author keywords

BCNU; Ethano adduct; Etheno adduct; Polymerase; Translesion DNA synthesis

Indexed keywords

1,N6 ETHANOADENINE; ADENINE DERIVATIVE; ANTINEOPLASTIC AGENT; CARMUSTINE; DNA; DNA POLYMERASE; PHOSPHORAMIDIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

CARCINOGENICITY; CATALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DNA ADDUCT; DNA SYNTHESIS; DRUG SYNTHESIS; ENZYME SUBUNIT; GENETIC CODE; HUMAN; IN VITRO STUDY; MAMMAL; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY;

MAMMALIA;

EID: 0344154365     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.07.006     Document Type: Conference Paper

References (59)

1. Ludlum D.B. The chloroethylnitrosoureas: sensitivity and resistance to cancer chemotherapy at the molecular level. Cancer Invest. 15:1997;588-598.
2. US Department of Health and Human Services, NTP, 10th Report on Carcinogens, 2002.
3. Fine H.A. The basis for current treatment recommendations for malignant gliomas. J. Neurooncol. 20:1994;111-120.
4. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans (Supplement 7), IARC Scientific Publications, Lyon, France, 1987.
5. Wiencke J.K., Wiemels J. Genotoxicity of 1,3-bis(2-chloroethyl)-1- nitrosourea (BCNU). Mutat. Res. 339:1995;91-119.
6. Minnick D.T., Veigl M.L., Sedwick W.D. Mutational specificity of 1,3-bis-(2-chloroethyl)-1-nitrosourea in a Chinese hamster ovary cell line. Cancer Res. 52:1992;4688-4695.
7. 6-alkylguanine-DNA alkyltransferase. Cancer Res. 53:1993;997-1003.
8. Ludlum D.B. DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. Mutat. Res. 233:1990;117-126.
9. Ludlum D.B. The chloroethylnitrosoureas: sensitivity and resistance to cancer chemotherapy at the molecular level. Cancer Invest. 15:1997;588-598.
10. D.B. Ludlum, Formation of cyclic adducts in nucleic acids by the haloethylnitrosoureas, in: B. Singer, H. Bartsch (Eds.), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis, vol. 70, IARC Scientific Publications, Lyon, France, 1986, pp. 137-146.
11. 1-deoxyguanosinyl]ethane in DNA treated with N,N′-bis(2-chloroethyl)-N-nitrosourea). Cancer Res. 42:1982;3102-3105.
12. Erickson L.C., Laurent G., Sharkey N.A., Kohn K.W. DNA cross-linking and monoadduct repair in nitrosourea-treated human tumor cells. Nature. 288:1980;727-729.
13. D.B. Ludlum, Q. Li, Z. Matijasevic, Role of base excision repair in protecting cells from the toxicity of chloroethylnitrosoureas, in: B. Singer, H. Bartsch (Eds.), Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis, vol. 150, IARC Scientific Publications, Lyon, France, 1999, pp. 271-278.
14. 2,3-ethanoguanine in DNA after in vitro treatment with the therapeutic agent, N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea. Carcinogenesis. 11:1990;223-228.
15. Leonard N.J. Etheno-bridged nucleotides in structural diagnosis and carcinogenesis. Biochem. Mol. Biol. Chemtracts. 3:1992;273-297.
16. H. Bartsch, Exocyclic adducts as new risk markers for DNA damage in man, in: B. Singer, H. Bartsch (Eds.), Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis, vol. 150, IARC Scientific Publications, Lyon, France, 1999, pp. 1-16.
17. Barbin A. Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat. Res. 462:2000;55-69.
18. 4-ethano, and 3-(2-hydroxyethyl) derivatives of 2′-deoxycytidine and their incorporation into oligomeric DNA. Chem. Res. Toxicol. 8:1995;148-156.
19. 4-Ethano-2′-deoxycytidine: chemistry of incorporation into oligomeric DNA and reassessment of miscoding potential. Nucl. Acids Res. 27:1999;4725-4733.
20. 6-ethano-2′-deoxyadenosine, a metabolic product of 1,3-bis(2-chloroethyl)nitrosourea, and its incorporation into oligomeric DNA. J. Org. Chem. 63:1998;4385-4389.
21. Guliaev A.B., Hang B., Singer B. Structural insights by molecular dynamics simulations into differential repair efficiency for ethano-A versus etheno-A adducts by the human alkylpurine-DNA-N-glycosylase (APNG). Nucl. Acid Res. 30:2002;3778-3787.
22. Johnson R.E., Washington M.T., Prakash S., Prakash L. Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA. Proc. Natl. Acad. Sci. U.S.A. 96:1999;12224-12226.
23. Woodgate R. A plethora of lesion-replicating DNA polymerases. Genes Dev. 13:1999;2191-2195.
24. Ohmori H., Friedberg E.C., Fuchs R.P., Goodman M.F., Hanaoka F., Hinkle D., Kunkel T.A., Lawrence C.W., Livneh Z., Nohmi T., Prakash L., Prakash S., Todo T., Walker G.C., Wang Z., Woodgate R. The Y-family of DNA polymerases. Mol. Cell. 8:2001;7-8.
25. Wang Z.-G. Translesion synthesis by the UmuC family of DNA polymerases. Mutat. Res. 486:2001;59-70.
26. Johnson R.E., Kondratick C.M., Prakash S., Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science. 285:1999;263-265.
27. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., Hanaoka F. The xeroderma pigmentosum variant (XPV) gene encodes human DNA polymerase η Nature. 399:1999;700-704.
28. Haracska L., Yu S.L., Johnson R.E., Prakash L., Prakash S. Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase η Nat. Genet. 25:2000;458-461.
29. Johnson R.E., Washington M.T., Haracska L., Prakash S., Prakash L. Eukaryotic polymerases ι and ζ act sequentially to bypass DNA lesions. Nature. 406:2000;1015-1019.
30. 6-methylguanine by yeast and human DNA polymerase η Mol. Cell. Biol. 20:2000;8001-8007.
31. Zhang Y., Yuan F., Wu X., Rechkoblit O., Taylor J.S., Geacintov N.E., Wang Z. Error-prone lesion bypass by human DNA polymerase η Nucl. Acids Res. 28:2000;4717-4724.
32. Masutani C., Kusumoto R., Iwai S., Hanaoka F. Mechanisms of accurate translesion synthesis by human DNA polymerase η EMBO J. 19:2000;3100-3109.
33. 6-ethenodeoxyadenosine. J. Biol. Chem. 276:2001;18717-18721.
34. Zhang Y., Yuan F., Wu X., Taylor J.-S., Wang Z. Response of human DNA polymerase ι to DNA lesions. Nucl. Acids Res. 29:2001;928-935.
35. 4-etheno-C, a potential carcinogenic glycidaldehyde product, miscodes in vitro using mammalian DNA polymerases. Biochemistry. 41:2002;1778-1785.
36. Fischhaber P.L., Gerlach V.L., Feaver W.J., Hatahet Z., Wallace S.S., Friedberg E.C. Human DNA polymerase kappa bypasses and extends beyond thymine glycols during translesion synthesis in vitro, preferentially incorporating correct nucleotides. J. Biol. Chem. 277:2002;37604-37611.
37. 4-methyldeoxythymidine triphosphate. Biochemistry. 28:1989;1478-1483.
38. 6- ethenodeoxyadenosine (εA): formation of εA basepairs and elongation in defined templates. Carcinogenesis. 18:1997;1609-1615.
39. Kunkel T.A., Bebenek K. DNA replication fidelity. Ann. Rev. Biochem. 69:2000;497-529.
40. Wilson S.H. Mammalian base excision repair and DNA polymerase β Mutat. Res. 407:1998;203-215.
41. Tissier A., Frank E.G., McDonald J.P., Iwai S., Hanaoka F., Woodgate R. Misinsertion and bypass of thymine-thymine dimers by human DNA polymerase ι EMBO J. 19:2000;5259-5266.
42. Frank E.G., Sayer J.M., Kroth H., Ohashi E., Ohmori H., Jerina D.M., Woodgate R. Translesion replication of benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyadenosine and deoxyguanosine by human DNA polymerase ι Nucl. Acids Res. 30:2002;5284-5292.
43. Zhang Y., Yuan F., Wu X., Wang Z. Preferential incorporation of G opposite template T by the low-fidelity human DNA polymerase ι Mol. Cell. Biol. 20:2000;7099-7108.
44. Tissier A., McDonald J.P., Frank E.G., Woodgate R. Pol ι, a remarkably error-prone human DNA polymerase. Genes Dev. 14:2000;1642-1650.
45. Vaisman A., Tissier A., Frank E.G., Goodman M.F., Woodgate R. Human DNA polymerase ι promiscuous mismatch extension. J. Biol. Chem. 276:2001;30615-30622.
46. Frank E.G., Tissier A., McDonald J.P., Rapic-Otrin V., Zeng X., Gearhart P.J., Woodgate R. Altered nucleotide misinsertion fidelity associated with pol ι-dependent replication at the end of a DNA template. EMBO J. 20:2001;2914-2922.
47. Yuan F., Zhang Y., Rajpal D.K., Wu X., Guo D., Wang M., Taylor J.-S., Wang Z. Specificity of DNA lesion bypass by the yeast DNA polymerase η J. Biol. Chem. 275:2000;8233-8239.
48. Singer B., Hang B. What structural features determine repair enzyme specificity and mechanism in chemically modified DNA? Chem. Res. Toxicol. 10:1997;713-732.
49. B. Singer, H. Bartsch, Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis, vol. 150, IARC Scientific Publications, Lyon, France, 1999, pp. 361.
50. Marnett L.J., Plastaras J.P. Endogenous DNA damage and mutation. Trends Genet. 17:2001;214-221.
51. Haracska L., Prakash L., Prakash S. Role of human DNA polymerase kappa as an extender in translesion synthesis. Proc. Natl. Acad. Sci. U.S.A. 99:2002;16000-16005.
52. 6-Ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry. 35:1996;11487-11492.
53. 6-ethenodeoxyadenosine adduct in human cells. Cancer Res. 60:2000;4098-4104.
54. Zhang Y., Wu X., Rechkoblit O., Geacintov N.E., Taylor J.-S., Wang Z. Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion. Nucl. Acids Res. 30:2002;1630-1638.
55. Sawaya M.R., Prasad R., Wilson S.H., Kraut J., Pelletier H. Crystal structures of human DNA polymerase β complexed with gapped and nicked DNA: evidence for an induced fit mechanism. Biochemistry. 36:1997;11205-11215.
56. Brautigam C.A., Steitz T.A. Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes. Curr. Opin. Struct. Biol. 8:1998;54-63.
57. Krahn J.M., Beard W.A., Miller H., Grollman A.P., Wilson S.H. Structure of DNA polymerase β with the mutagenic DNA lesion 8-oxodeoxyguanine reveals structural insights into its coding potential. Structure (Camb.). 11:2003;121-127.
58. Trincao J., Johnson R.E., Escalante C.R., Prakash S., Prakash L., Aggarwal A.K. Structure of the catalytic core of S. cerevisiae DNA polymerase η: implications for translesion DNA synthesis. Mol. Cell. 8:2001;417-426.
59. Ling H., Boudsocq F., Woodgate R., Yang W. Crystal structure of a Y family DNA polymerase in action: a mechanism for error-prone and lesion-bypass replication. Cell. 107:2001;91-102.